Sarcopenia: Muscle Loss After 50 and How to Prevent It

What is sarcopenia and why does muscle loss matter after 50?

Sarcopenia is the progressive, age-related loss of skeletal muscle — and crucially, it's defined by loss of strength first, not just size. The European Working Group on Sarcopenia in Older People (EWGSOP2) sets out a three-part framework: low muscle strength makes sarcopenia probable; low muscle quantity or quality confirms it; and poor physical performance marks its severity (EWGSOP2 consensus, Age and Ageing).

This matters after 50 because muscle is what keeps you mobile, steady on your feet and able to recover from illness or surgery. Sarcopenia is now formally recognised as a disease — it received its own ICD-10 diagnostic code in 2016 — yet, as a UK primary-care review notes, it is still very rarely diagnosed or documented in British medical records (British Journal of General Practice). Most people lose muscle silently, with no one tracking it.

How fast do you actually lose muscle as you age — and when does it accelerate?

Muscle decline is gradual at first and then steepens with age. A quantitative review of skeletal-muscle ageing found cross-sectional losses of about 0.47% of muscle mass per year in men and 0.37% per year in women, with the rate climbing sharply after 75 — longitudinal data put it at roughly 0.64–0.70% per year in women and 0.80–0.98% per year in men over 75 (quantitative review of muscle ageing).

The more important number, though, isn't mass — it's strength. The same review found that muscle strength is lost two to five times faster than muscle mass, and that strength loss is a more consistent predictor of disability and death than mass loss. In other words, you can lose meaningful function before you'd notice much change in size.

There's a sex dimension worth naming carefully. Evidence suggests that the reduction in muscle mass and strength in postmenopausal women is typically greater than in age-matched men (Frontiers in Endocrinology review). Both sexes show a noticeable decline from around the mid-fifties — the source records grip-strength and knee-strength drops after 55 in men as well as women — so this is a general inflection of ageing, not a menopause-only one.

What causes sarcopenia: inactivity, poor diet, menopause, or something else?

It's rarely one thing. Sarcopenia is multifactorial, and the major contributing drivers stack on top of each other:

• Physical inactivity — muscle responds to load, so reduced activity removes the stimulus that keeps it.
• Inadequate protein and overall nutrition — without enough protein, the body can't rebuild muscle effectively.
• Hormonal change — for women, the fall in oestrogen around and after menopause is one contributing driver. Oestrogen appears to support muscle protein synthesis and limit breakdown, so its decline likely plays a role — but the research presents this as a mechanistic argument alongside age, activity, nutrition and inflammation, not as the sole or proven cause (Frontiers in Endocrinology review).
• Chronic inflammation and illness — long-term conditions accelerate muscle breakdown.

Because the causes are largely lifestyle-linked, the encouraging flip side is that the most powerful levers — movement and diet — are within reach for most people.

What are the warning signs of sarcopenia and how is it diagnosed in the UK?

The early signs are easy to dismiss as "just getting older": finding it harder to rise from a chair, climb stairs or carry shopping; a weaker grip; slower walking; unsteadiness or more frequent stumbles. These reflect the strength and performance losses at the heart of sarcopenia.

In the UK, diagnosis usually starts in primary care. There is no single routine NHS screening programme, but GPs can use the SARC-F questionnaire as a quick case-finding tool — a score of 4 or more flags a likely case and prompts further assessment (British Journal of General Practice). From there, the EWGSOP2 pathway adds an objective grip-strength measurement — with confirmation thresholds of below 27 kg for men and below 16 kg for women — followed, where available, by a measure of muscle quantity and a physical-performance test such as gait speed (EWGSOP2 consensus).

If you recognise these signs in yourself or a relative, it's worth raising with a GP rather than waiting — early identification is when prevention works best.

Why are muscle loss and bone loss so closely linked — and what is osteosarcopenia?

Muscle and bone aren't separate systems — they talk to each other constantly. Working muscle pulls on bone and signals it to stay strong, but the link runs deeper than mechanics. Muscle secretes myostatin, which tends to lower bone density, while bone releases osteocalcin, a form of which appears to help preserve muscle mass and grip strength (osteosarcopenia crosstalk review). When both tissues decline together, the combined condition is called osteosarcopenia.

That overlap carries real consequences. In an age- and sex-matched analysis of people aged 50 and over, those with osteosarcopenia had a higher major-osteoporotic-fracture rate than those with osteoporosis alone (21.25% vs 17.97%), lower independence on the Barthel daily-living index (91.80 vs 97.60), and around 23% were at high risk of falls — with women affected more than men (osteosarcopenia outcomes analysis).

What actually works to prevent sarcopenia: resistance exercise and protein explained

The strongest evidence points to two things done together: resistance exercise and adequate protein.

Resistance (strength) training provides the anabolic stimulus muscle needs to grow and hold — it is repeatedly described as the primary, evidence-based management for sarcopenia (Nutrients review; British Journal of General Practice). In practice that means working your muscles against resistance — weights, bands, or bodyweight moves like sit-to-stands — a few times a week, progressing gradually.

Protein supplies the raw material. The same review supports an intake of around 1.0–1.3 g of protein per kg of body weight per day to help sustain muscle mass in older adults, with at least roughly 0.6 g/kg spread into each main meal to maximise the muscle-building response (Nutrients review).

Combined, they outperform either alone. A 2024 systematic review and meta-analysis of older adults with sarcopenia (7 randomised controlled trials and 1 quasi-experimental study, n=854) found that protein supplementation plus resistance exercise improved muscle mass (SMD 0.95, 95% CI 0.13–1.78) and handgrip strength (SMD 0.32, 95% CI 0.08–0.56, p=0.009) (meta-analysis). The handgrip effect was statistically robust; the muscle-mass effect, while significant, had a wide confidence interval that came close to zero at its lower bound — so the direction is clear, but the precise size is uncertain. Before increasing protein substantially, anyone with kidney disease should check with their GP first.

Do vitamin D and omega-3 supplements prevent sarcopenia? What the evidence really shows

On current evidence, supplements are not a substitute for exercise. The DO-HEALTH randomised controlled trial followed 2,157 adults aged 70 and over for three years, testing 2,000 IU of vitamin D daily, 1 g of omega-3 daily, and a thrice-weekly home exercise programme, alone and in combination. None of the treatments meaningfully prevented muscle-mass loss or new cases of sarcopenia. Omega-3 showed a small protective effect on muscle mass at year one that did not persist, and the authors concluded they could not recommend vitamin D or omega-3 for muscle health in this group (DO-HEALTH trial).

One scope caveat is essential here: DO-HEALTH studied healthy, active adults aged 70+. Its null result should not be stretched to people who are vitamin D deficient, frail, or already diagnosed with sarcopenia — those groups weren't tested and may respond differently. The honest takeaway is narrower than the headlines: in generally well older people, supplements don't replace strength training and protein.

How does a bone health assessment fit into your muscle-health picture?

A bone health assessment doesn't measure muscle — but it can be the moment the muscle conversation starts. Because bone and muscle decline together as osteosarcopenia, the same risk factors — being over 50, post-menopausal, inactive, or under-eating protein — apply to both. Sitting down to look at your bones is a natural prompt to ask the next question: how is my muscle and strength holding up?

To be clear about what the technology does: a REMS bone scan measures bone density only — it does not detect, screen for, or diagnose sarcopenia. What a bone health assessment can do is give you an objective baseline for one half of the muscle–bone picture and open a structured conversation about the other half — including the strength, nutrition and activity habits that protect both. Because REMS is radiation-free, that baseline can be repeated safely over time to track change.

If muscle and bone health are on your mind, you can book a screening, explore our services and assessment days, or see where we screen across the UK.

The bottom line

Sarcopenia is common, under-recognised, and — unusually for an age-related condition — substantially modifiable. The evidence consistently lands in the same place: resistance exercise plus adequate protein is the defence that works, supplements are not a shortcut, and muscle and bone are best thought about together. Knowing where you stand on one half of that picture, your bones, is a sensible first step.

---

This article is part of our muscle health and sarcopenia series. To understand the muscle–bone connection further, see our bone health guides and our piece on weight-loss injections and bone loss.